Advanced Search

 

Study ID Status Title Patient Level Data
201314 Completed A randomized, parallel group study to evaluate the effect of Umeclidinium (UMEC) added to Inhaled corticosteroid/ long-acting beta-agonist combination therapy in subjects with Chronic Obstructive Pulmonary Disease COPD
201315 Completed A Randomized, Parallel-group, Open-label Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Glycopyrronium 44 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201316 Completed A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Tiotropium 18 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201317 Completed A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effect of the Combination of Umeclidinium and Vilanterol on Exercise Endurance Time in Subjects with COPD
201318 Completed PGx7530: Genetics of Mepolizumab (SB240563) Treatment Response in Severe Asthmatics in MEA115588
201327 Active not recruiting Boostrix® Pregnancy Registry: a prospective, exploratory, cohort study to detect and describe any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with Boostrix® during pregnancy or within 28 days preceding conception
201330 Recruiting Immunogenicity and safety study of GSK Biologicals’ combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-virus and Haemophilus influenzae type b vaccine (Infanrix hexa™) (217744) in healthy infants born to mothers vaccinated with Boostrix™ during pregnancy or immediately post-delivery
201334 Recruiting Immunogenicity and safety study of a booster dose of GSK Biologicals’ Infanrix hexa™ (217744) in healthy infants born to mothers vaccinated with Boostrix™ during pregnancy or immediately post-delivery
201335 Completed Incidence of hepatitis B diagnosis among diabetes mellitus patients of 0-80 years of age, in the United Kingdom Clinical Practice Research Datalink (CPRD)
201344 Completed A Preference Study of Inhaler Attributes Between Two inhalers; ELLIPTA and MDI, in Adult Subjects with Asthma
201351 Completed A Randomized, Placebo Controlled, Repeat Dose, Double Blind (sponsor unblind) Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered with Metformin to Type 2 Diabetes Patients Study Listed on ClinicalStudyDataRequest.com
201355 Not yet recruiting A Prospective Observational Study of Oral Oncolytic Therapies in Metastatic Melanoma Populations: A Post-Market Analysis of Utilization Patterns
201357 Active not recruiting Health care resource use and costs associated with use of mepolizumab versus placebo in a clinical trial setting
201358 Active not recruiting Systematic Literature Review and Meta-Analysis of Side Effects of Treatments Used in Advanced Soft Tissue Sarcoma
201360 Not yet recruiting HO-14-14418 - Outcomes of first-line pazopanib and sunitinib users and sequential use of pazopanib followed by mTORi therapy among patients with advanced/metastatic renal cell carcinoma in a U.S. community oncology setting.
201362 Completed Administrative database study describing the prevalence of CVD in COPD patients, its impact on exacerbations and health care utilization.
201363 Completed Treatment Pathways in an Inception Lupus Cohort in Atlantic Canada
201364 Active not recruiting Active Lupus in Canada
201365 Recruiting Special Drug Use Investigation of LAMICTAL Tablets in Patients with Epilepsy (Investigation on Switching to Monotherapy)
201373 Completed Characterization of patients with Chronic Lymphocytic Leukemia in British Columbia, Canada using a province-wide CLL database
201376 Active not recruiting Understanding Current Patterns of Care and Planning for the Future – A Retrospective Observtional Study in Melanoma
201378 Completed A randomized, double-blind, double-dummy, parallel group, multicenter study of once daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, twice daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and twice daily Fluticasone Propionate 250 mcg Inhalation Powder in the treatment of persistent asthma in adults and adolescents already adequately controlled on twice-daily inhaled corticosteroid and long-acting beta2 agonist
201379 Active not recruiting Patterns of Care for Patients with Metastatic Renal Cell Carcinoma in a United States Population
201390 Active not recruiting Impact of Disease Activity on Mortality and Damage Progression in Systemic Lupus Erythematosus (SLE) Patients with Active Disease despite Standard of Care in the Toronto Lupus Cohort
201393 Completed PGx7572: An Exploratory Investigation of CYP2D6 Activity and Efficacy of tafenoquine and primaquine in TAF112582 Part 1

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.